MMM — Q2 2026 Financial Report Analysis
Q2 · Fiscal year 2026 · Published Sep 12, 2026 by Claude
Adjusted organic sales grew 5.4%, but the 33% GAAP EPS growth is mostly one-off items: a $336M divestiture loss, a swing in Solventum stake value, and lower PFAS litigation costs, not operating improvement.
Overview
3M's GAAP EPS of $1.78 for the second quarter, up 33% from $1.34 a year earlier, is not a clean read on operating performance. The company's own reconciliation shows GAAP EPS included a $0.61 loss on business divestitures (versus none a year ago), a $0.60 favorable swing in the value of its retained Solventum ownership stake, and $0.44 of net PFAS/litigation costs (down from $0.79 a year ago). Strip these out and adjusted EPS was $2.40, up 11% year-over-year — a more modest but more representative number. Adjusted organic sales growth was 5.4%, ahead of the 2.4% GAAP total sales growth, with the gap explained by divestitures and currency.
Key Financial Metrics
| Metric | Q2 2026 | Q2 2025 | YoY Change |
|---|---|---|---|
| Net sales (GAAP) | $6.50B | $6.34B | +2.4% |
| Adjusted organic sales growth | +5.4% | — | — |
| Operating income (GAAP) | $984M | $1,140M | -14% |
| Adjusted operating margin | 24.9% | 24.5% | +40bps |
| GAAP EPS | $1.78 | $1.34 | +33% |
| Adjusted EPS | $2.40 | $2.16 | +11% |
Takeaway: GAAP operating income fell 14% year-over-year, in the same quarter GAAP EPS rose 33% — the divergence is the $336 million divestiture loss sitting in operating income, versus the Solventum stake gain sitting below the operating line in other income. Reading either GAAP figure alone gives a materially wrong picture of the quarter; the adjusted EPS growth of 11% is the number that reflects what the business actually did.
Segment and Geographic Detail
Organic sales growth by segment: Safety and Industrial +8.2%, Transportation and Electronics +5.9%, Consumer -2.1%. Consumer is the one segment where the underlying business contracted, not just a currency or divestiture effect. By geography, organic growth was strongest in China (+9.2%) and Latin America (+5.4%), while United States and Canada organic sales were flat (0.0%) and total sales in that region declined 0.5% once translation is included. The growth this quarter is concentrated outside the US, and Consumer is a genuine drag rather than a rounding effect.
One-Off Items Driving the GAAP Numbers
Three items account for most of the gap between GAAP and adjusted results this quarter: a $336 million loss on business divestitures recorded in operating expenses (versus $3 million a year ago), a swing in the market value of 3M's retained Solventum equity stake that added $0.60 to GAAP EPS (versus adding only $0.01 a year ago), and $0.44 per share of net PFAS-related litigation and exit costs, which is down from $0.79 per share a year ago — a real improvement, but still a substantial ongoing cost. None of the divestiture loss or the Solventum stake revaluation reflects 3M's core industrial operations.
Guidance
3M raised full-year 2026 adjusted EPS guidance to $8.80-$8.95 (from $8.50-$8.70), on adjusted organic sales growth guidance of above 3.5% and adjusted operating margin expansion of 70-80 basis points. This guidance does not yet include the Madison Fire & Rescue acquisition, which closed July 1, 2026, after the quarter ended.
Other Disclosure
3M and Microsoft announced a partnership under which Microsoft will deploy 3M's Expanded Beam Optics (EBO) fiber-connectivity technology in its hyperscale data centers; 3M states Microsoft is the first hyperscale cloud provider to adopt this technology. This is a supply-chain entry into AI data center infrastructure for 3M, outside its traditional industrial and consumer end markets, though the filing gives no revenue figures attached to it.
More 3M reports
Recent in Industrials
- Ametek (AME) · Q2 2026AME — Q2 2026 Financial Report Analysis
AMETEK posted record Q2 2026 sales of $2.04 billion (+15%, of which 10 points organic) and adjusted EPS of $2.09, but the bigger signal was a 28% jump in orders that lifted backlog to a record $4.11 billion — even as management guided the second half to roughly 7% sales growth.
- Allegion (ALLE) · Q2 2026ALLE — Q2 2026 Financial Report Analysis
Allegion grew Q2 2026 revenue 12.7% to $1,151.5 million and raised full-year guidance, but only 6.9% was organic — an accelerating Americas business (+8.9% organic) masking an International segment whose revenue fell 1.2% organically and whose pre-acquisition operations lost $6.6 million of operating income.
- A. O. Smith (AOS) · Q1 2026AOS — Q1 2026 Financial Report Analysis
A. O. Smith's Q1 2026 sales fell 1.9% to $945.6M, but currency and the Leonard Valve acquisition masked a ~5% underlying volume decline, and a 17% local-currency drop in China forced a cut to full-year EPS guidance.